Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global
innovator in drug delivery platforms, on Tuesday announced that its Chief
Executive Officer, Chris Bunka, will present live at
LifeSciencesInvestorForum.com on March 26. According to the update, Bunka’s
presentation is scheduled to begin at 12:00 PM ET. The live, interactive online
event invites investors to ask the company questions in real-time. It is
suggested that interested parties pre-register and run the online system check
to expedite participation and receive event updates. An archived webcast will
be made available after the event for those unable to join live on the day of
the conference.
To register and view event details, visit http://ibn.fm/oo2ZH
To view the full press release, visit http://ibn.fm/Inoxi
About Lexaria Bioscience
Lexaria Bioscience Corp. is a global innovator in drug
delivery platforms. Its patented DehydraTECH(TM) drug delivery technology
changes the way API’s enter the bloodstream, promoting healthier ingestion
methods, lower overall dosing and higher effectiveness for lipophilic active
molecules. DehydraTECH increases bio-absorption; reduces time of onset; and can
reduce drug costs for orally administered bioactive molecules including
nicotine, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and other
molecules. Lexaria has licensed DehydraTECH to multiple companies for use in
various oral application formats, including to a world-leading tobacco producer
for the development of smokeless, oral-based nicotine products. Lexaria
operates a licensed in-house research laboratory and holds a robust
intellectual property portfolio with 16 patents granted and over 60 patents pending
worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates
relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment